Pharmacovigilance is described by the World Health Organization (WHO) as “the science and activity related to the identification, analysis, understanding, and prevention of side effects or any other drug-related problems.”
A pharmacovigilance system is a segment of a pharmaceutical corporation that is designed to manage the safety profile of all pharmaceuticals and medicinal goods and notice any change in the balance of their risks and benefits. To cope effectively with this process, pharmacovigilance and clinical research training can be beneficial.
It is also developed on quality improvements, quality standards and assurance, which involve adjusting and improving processes and structures, as well as effective supervision and evaluation of existing procedures.
Good pharmacovigilance practice guidelines must be followed at all instances in order to achieve certain objectives. These principles assist in the development of the best structures and processes to achieve the desired goals.
Guidelines include:
- In compliance with appropriate legal regulations, good connections and coordination with the appropriate authorities and public health groups should be fostered.
- The services and tasks should indeed be planned so that pharmacovigilance is conducted in a proactive, continuous, integrated, risk-proportionate, and based on cooperation.
- All criteria focusing on patients, healthcare providers, and public health must be met on the only principle of safety.
- All people in the organization should be active in promoting the vigilance system based on the particular roles and the duty of ownership and accountability for the highest possible degree of quality.
- Higher management positions should have effective management characteristics and be committed to empowering the team to achieve the outlined goals.
- All departments participating in pharmacovigilance should have a very productive and cooperative relationship. Cooperation should be at an all-time high, primarily with the marketing department.
New diseases and illnesses necessitate an appropriate treatment with significant safety margins. This makes pharmacovigilance more crucial than ever before. The preceding recommendations must therefore be followed for a better pharmacovigilance department.
Thus, interactions with the medications or drug, abuse and misuse of the medication or drug, medical mistakes, lack of efficacy, adverse outcomes, and good cooperation are all examples of good pharmacovigilance techniques.
